Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Filing tables
Filing exhibits
QNTA similar filings
- 24 Jun 22 Other Events
- 16 Jun 22 Entry into a Material Definitive Agreement
- 4 May 22 Medolife Rx Schedules Conference Call with Investment Community to Discuss New Updates and Answer Questions
- 27 Apr 22 Changes in Registrant's Certifying Accountant
- 19 Nov 21 Medolife Rx Schedules Conference Call with Investment Community To Discuss Third Quarter 2021 Financial and Operational Results and New Updates
- 29 Sep 21 Entry into a Material Definitive Agreement
- 24 Aug 21 Medolife Rx Reports Second Quarter 2021 Financial and Operational Results, Schedules Conference
Filing view
External links
Exhibit 16.2
April 25, 2022
Securities and Exchange Commission
100 F Street, N.E.
Washington, D.C. 20549-7561
Dear Sirs/Madams:
We have read Item 4.01 of Quanta Inc.’s Form 8-K dated April 22, 2022, and to be filed April 25, 2022, and agree with the statements made therein insofar as they relate to our Firm.
Yours truly,
/s/ Weinberg & Company, P.A.
Los Angeles, California